A new deal protects Australians chemists at the expense of patients

22 September 2019 - Australia’s 3000 pharmacy owners have a government guaranteed monopoly that is pushing up medicine prices and the ...

Read more →

Addition of Kisqali to drug plan in Quebec expands access to treatment for metastatic breast cancer

19 September 2019 - Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer. ...

Read more →

National pharmacare cheaper than healing people who can't afford their drugs

17 September 2019 - A national pharmacare program could potentially reduce prescription drug spending by aggregating the buying power of all ...

Read more →

5 people setting EU drug prices

19 September 2019 - Politic’s guide to the policy makers debating how to calculate the cost of cures. ...

Read more →

Electronic prescribing

19 September 2019 - Electronic Prescribing will provide an option for prescribers (including doctors, dentists, optometrists, midwives and nurse practitioners), and ...

Read more →

Xanax still being overprescribed despite policy changes

19 September 2019 - Patients are still being prescribed hundreds of Xanax tablets a year despite a cut in government ...

Read more →

Health technology agency insights: informing modification of a qualitative benefit risk framework for health technology reassessment of prescription medications

16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified ...

Read more →

Three-year-old Matilda's ability to walk is giving hope to those with spinal muscular atrophy

18 September 2019 - The disease, which has been described as motor neurone disease for children, is the leading cause of ...

Read more →

NICE recommends Takhzyro

18 September 2019 - NICE - a health technology appraisal body in England and Wales - has recommended the use ...

Read more →

'A child's health should not be a postcode lottery': anger of cystic fibrosis sufferers forced to pay £20,000 for drug abroad

17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...

Read more →

News NHS England explores funding options for cystic fibrosis drug

17 September 2019 - NHS England is “committed to exploring and developing alternative routes” to enable people with cystic fibrosis ...

Read more →

PHARMAC may have to compete for measles vaccine

17 September 2019 - PHARMAC is looking at whether it can order more measles vaccine in case the latest batch runs ...

Read more →

HTA in the European Union: osteoporosis screening without proof of benefit

16 September 2019 - For the first time, an IQWiG team is in charge of assessing health technology for the ...

Read more →

Canada decides: Leading parties plan to tackle ways to make medicine affordable

16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...

Read more →

Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)

12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...

Read more →